Tyler Chandler, Nick Meyers and Adrianne - Dosed Movie: Psychedelics and Mental Health
Psychedelics Today16 Kesä 2020

Tyler Chandler, Nick Meyers and Adrianne - Dosed Movie: Psychedelics and Mental Health

In this episode, Joe Interviews Dosed filmmakers Tyler Chandler and Nick Meyers, as well as the subject of their documentary, Adrianne.

Show Notes

Nick and Tyler tell the story of how they went from really knowing very little about the psychedelic healing movement to becoming advocates solely from a panicked call from Adrianne.

Adrianne speaks of her journey from opiate addiction and severe depression to trying mushrooms and eventually learning she needed Iboga and a community around her to really fight her way out of a life she no longer wanted to live.

They touch on the costs of Iboga compared to other rehabilitation methods, the often glazed-over dangers of Iboga, the effectiveness of psilocybin against opioid withdrawal, anxiety in the western world, holotropic breathwork as a safer method towards healing, the power of the Pixar movie, Inside Out, and why it would be beneficial for young viewers to watch Dosed.

Resources

www.dosedmovie.com

Notable Quotes

"I have gotten sober and detoxed many, many, many times and not stayed sober, so obviously while the physical withdrawals are completely excruciating and definitely a big barrier to getting sober, there's really something more to recovery than that, and that's that kind of spiritual experience or awakening. And the psychedelic component is really important to that and I feel like that's what's contributed to me... not only getting sober but staying sober." -Adrianne

"The real problem is that… people are forced to make these decisions and take these risks because something that has been known for 40 years to have this wonderful effect on opioid addicts is somehow something that nobody knows about and isn't legalized." -Nick Meyers

"No matter how you choose to recover or what you do to get sober and stay sober, having a community around you and staying connected with people is so, so important." -Adrianne

"I definitely had a lot of discomfort just learning to… be still or be with myself and not have an escape. That's part of recovery and it's very uncomfortable. It takes time to get used to that. I was always used to having some kind of coping mechanism that took me out of myself, that just helped me not feel uncomfortable or whatever negative feeling I was feeling. So that's always a challenge and there's no shortcuts to that- you do have to just learn to be in your body and feel feelings, which I did not like very much. But, you know, it gets easier over time." -Adrianne

"Everybody is so scared of just saying... 'this is something that teens should do' because nobody wants to have anything bad happen and then have it get traced back to them. But look at the realities of what teens are going through with... the rampant alcohol and other drugs, and… vaping and smoking and all the other vices- prescription medications, everything that's available. And there's like, no guidance, no supervision a lot of the time… What we're doing right now isn't working. Can I dare say it? It would be better if there were rites of passage with psychedelics in controlled settings with proper set, setting and dose with young people, because it really helps you recontextualize and reframe things in your mind." -Nick Meyers

About Dosed

After many years of prescription medications failed her, a suicidal woman turns to underground healers to try and overcome her depression, anxiety, and opioid addiction with illegal psychedelic medicine such as magic mushrooms and iboga. Adrianne's first dose of psilocybin mushrooms catapulted her into an unexpected world of healing where plant medicines are redefining our understanding of mental health and addiction.

Support the show

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(774)

PT568 – The 3-Axis Framework: A New Model for Psychedelic Work, with Pierre Bouchard, LPC, LM

PT568 – The 3-Axis Framework: A New Model for Psychedelic Work, with Pierre Bouchard, LPC, LM

In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry. Bouchard introduces h...

26 Marras 20241h 9min

PT567 – Sex and Psychedelics: Healing Through Altered States, with Bria Tavakoli, LPCC, MA, MS

PT567 – Sex and Psychedelics: Healing Through Altered States, with Bria Tavakoli, LPCC, MA, MS

In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her p...

22 Marras 20241h 13min

PT566 – Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry, with Juan Pablo Cappello

PT566 – Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry, with Juan Pablo Cappello

In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges ...

19 Marras 20241h 33min

PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.

PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.

In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketami...

15 Marras 20241h 8min

PT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel

PT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found t...

11 Marras 20241h 8min

PT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk

PT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, tri...

8 Marras 20241h 29min

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assist...

5 Marras 202445min

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

In this episode, Joe and Kyle finally meet up again for the first episode of Psychedelics Lately: the updated version of the much-missed Psychedelics Weekly, where they'll meet each month to talk abou...

1 Marras 202455min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
docemilia
rss-duodecim-lehti
rss-tiedetta-vai-tarinaa
rss-totuuden-liepeilla
university-of-eastern-finland
filocast-filosofian-perusteet
rss-bios-podcast
rss-duokkari-ekstra
rss-laakaripodi
rss-astetta-parempi-elama-podcast
rss-ylistys-elaimille